DK1114062T3 - Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt protein - Google Patents
Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt proteinInfo
- Publication number
- DK1114062T3 DK1114062T3 DK99944889T DK99944889T DK1114062T3 DK 1114062 T3 DK1114062 T3 DK 1114062T3 DK 99944889 T DK99944889 T DK 99944889T DK 99944889 T DK99944889 T DK 99944889T DK 1114062 T3 DK1114062 T3 DK 1114062T3
- Authority
- DK
- Denmark
- Prior art keywords
- modified
- peptide
- heterologous protein
- signal peptide
- coli enterotoxin
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 101710146739 Enterotoxin Proteins 0.000 title abstract 4
- 241000588724 Escherichia coli Species 0.000 title abstract 4
- 108010076504 Protein Sorting Signals Proteins 0.000 title abstract 4
- 239000000147 enterotoxin Substances 0.000 title abstract 4
- 231100000655 enterotoxin Toxicity 0.000 title abstract 4
- 244000005700 microbiome Species 0.000 title abstract 2
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 210000001322 periplasm Anatomy 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
- 108091005601 modified peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019980038061A KR100316347B1 (ko) | 1998-09-15 | 1998-09-15 | 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법 |
| PCT/KR1999/000547 WO2000015661A1 (fr) | 1998-09-15 | 1999-09-15 | Peptide signal d'enterotoxine ii de e. coli modifie et micro-organisme exprimant une proteine de fusion dudit peptide et proteine heterologue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1114062T3 true DK1114062T3 (da) | 2006-06-06 |
Family
ID=36120918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99944889T DK1114062T3 (da) | 1998-09-15 | 1999-09-15 | Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt protein |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6605697B1 (fr) |
| EP (1) | EP1114062B1 (fr) |
| JP (1) | JP3701201B2 (fr) |
| KR (1) | KR100316347B1 (fr) |
| CN (1) | CN1144815C (fr) |
| AT (1) | ATE317398T1 (fr) |
| AU (1) | AU754435B2 (fr) |
| BR (1) | BRPI9913698B1 (fr) |
| CA (1) | CA2342537C (fr) |
| DE (1) | DE69929805T2 (fr) |
| DK (1) | DK1114062T3 (fr) |
| NZ (1) | NZ510385A (fr) |
| RU (1) | RU2198179C2 (fr) |
| WO (1) | WO2000015661A1 (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6242177B1 (en) * | 1995-03-01 | 2001-06-05 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| KR100356140B1 (ko) | 1999-07-08 | 2002-10-19 | 한미약품공업 주식회사 | 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법 |
| KR100360594B1 (ko) * | 2000-01-19 | 2002-11-13 | 한미약품공업 주식회사 | 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법 |
| KR100570422B1 (ko) * | 2003-10-16 | 2006-04-11 | 한미약품 주식회사 | 대장균 분비서열을 이용하여 항체 단편을 분비·생산하는 발현벡터 및 이를 이용하여 항체 단편을 대량 생산하는 방법 |
| US8110665B2 (en) | 2003-11-13 | 2012-02-07 | Hanmi Holdings Co., Ltd. | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| MXPA05007210A (es) | 2003-11-13 | 2006-02-10 | Hanmi Pharm Ind Co Ltd | Complejo de proteina que usa un fragmento de inmunoglobulina y metodo para la preparacion del mismo. |
| EP2049148B1 (fr) | 2006-07-06 | 2016-09-28 | Daewoong Co., Ltd. | Formulation liquide stable à base d'hormone de croissance humaine |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| KR101831300B1 (ko) | 2010-10-29 | 2018-02-23 | 한미사이언스 주식회사 | 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법 |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2017180587A2 (fr) | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Systèmes de biocircuits régulés |
| EA037848B1 (ru) | 2016-07-14 | 2021-05-27 | Общество С Ограниченной Ответственностью "Биохимический Агент" | Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты) |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2019241315A1 (fr) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Constructions régulatrices dérivées de pde5 et procédés d'utilisation en immunothérapie |
| EP3870600A1 (fr) | 2018-10-24 | 2021-09-01 | Obsidian Therapeutics, Inc. | Régulation de protéine accordable par er |
| WO2020185632A1 (fr) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Compositions d'anhydrase carbonique humaine 2 et procédés de régulation accordable |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| JP2022537670A (ja) | 2019-06-12 | 2022-08-29 | オブシディアン セラピューティクス， インコーポレイテッド | Ｃａ２の組成物および調整可能な制御方法 |
| US20220267398A1 (en) | 2019-06-12 | 2022-08-25 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| US20220348937A1 (en) | 2019-09-06 | 2022-11-03 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
| US12285437B2 (en) | 2019-10-30 | 2025-04-29 | The Research Foundation For The State University Of New York | Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| MX2023006704A (es) | 2020-12-15 | 2023-06-20 | Arvada Therapeutics Inc | Composiciones dsg2 y metodos para el tratamiento de covid-19. |
| AR127555A1 (es) | 2021-11-02 | 2024-02-07 | Arvada Therapeutics Inc | Composiciones y métodos que comprenden dsg2 asociados a enfermedades cardíacas |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5308835A (en) * | 1984-07-09 | 1994-05-03 | Praxis Biologics, Inc. | Production of the E. coli LT-B enterotoxin subunit |
| DE3586386T2 (de) * | 1984-10-05 | 1993-01-14 | Genentech Inc | Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung. |
| JPS63230089A (ja) * | 1987-03-18 | 1988-09-26 | Takeda Chem Ind Ltd | 分泌発現による蛋白質の製造法 |
| JPH0479898A (ja) * | 1990-07-23 | 1992-03-13 | Kitasato Inst:The | コレラ菌及び毒素原性大腸菌を同時検出するためのｄｎａ及びｒｎａプローブとそれらを用いたコレラ菌及び毒素原性大腸菌の検出方法 |
| EP0626448A3 (fr) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Procédé de la préparation et de purification d'interféron-alpha |
-
1998
- 1998-09-15 KR KR1019980038061A patent/KR100316347B1/ko not_active Expired - Lifetime
-
1999
- 1999-09-15 DK DK99944889T patent/DK1114062T3/da active
- 1999-09-15 CN CNB99810924XA patent/CN1144815C/zh not_active Expired - Lifetime
- 1999-09-15 RU RU2001110120/04A patent/RU2198179C2/ru active
- 1999-09-15 BR BRPI9913698A patent/BRPI9913698B1/pt not_active IP Right Cessation
- 1999-09-15 AT AT99944889T patent/ATE317398T1/de not_active IP Right Cessation
- 1999-09-15 CA CA002342537A patent/CA2342537C/fr not_active Expired - Lifetime
- 1999-09-15 AU AU57618/99A patent/AU754435B2/en not_active Expired
- 1999-09-15 NZ NZ510385A patent/NZ510385A/xx not_active IP Right Cessation
- 1999-09-15 WO PCT/KR1999/000547 patent/WO2000015661A1/fr not_active Ceased
- 1999-09-15 JP JP2000570199A patent/JP3701201B2/ja not_active Expired - Lifetime
- 1999-09-15 DE DE69929805T patent/DE69929805T2/de not_active Expired - Lifetime
- 1999-09-15 EP EP99944889A patent/EP1114062B1/fr not_active Expired - Lifetime
- 1999-09-15 US US09/786,569 patent/US6605697B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015661A1 (fr) | 2000-03-23 |
| CA2342537C (fr) | 2008-07-08 |
| EP1114062A1 (fr) | 2001-07-11 |
| EP1114062B1 (fr) | 2006-02-08 |
| CA2342537A1 (fr) | 2000-03-23 |
| ATE317398T1 (de) | 2006-02-15 |
| JP2002538765A (ja) | 2002-11-19 |
| JP3701201B2 (ja) | 2005-09-28 |
| NZ510385A (en) | 2002-12-20 |
| DE69929805D1 (de) | 2006-04-20 |
| US6605697B1 (en) | 2003-08-12 |
| BRPI9913698B1 (pt) | 2016-06-21 |
| RU2198179C2 (ru) | 2003-02-10 |
| CN1318070A (zh) | 2001-10-17 |
| DE69929805T2 (de) | 2006-10-26 |
| KR20000019788A (ko) | 2000-04-15 |
| CN1144815C (zh) | 2004-04-07 |
| AU5761899A (en) | 2000-04-03 |
| KR100316347B1 (ko) | 2002-08-27 |
| BR9913698A (pt) | 2002-01-29 |
| AU754435B2 (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1114062T3 (da) | Modificeret E. coli-enterotoksin II-signalpeptid og en mikroorganisme, som eksprimerer et fusionsprotein af peptidet og et heterologt protein | |
| CN100500853C (zh) | 用于向细菌培养物上清液中分泌目的蛋白质的融合蛋白质 | |
| EP0722461A4 (fr) | Expression de polypeptides de fusion transportes hors du cytoplasme sans sequence de tete | |
| ATE421977T1 (de) | Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie | |
| AU7550098A (en) | System for expressing hyperthermostable protein | |
| PT1124941E (pt) | Processo para recuperar polipeptidos heterologos a partir de celulas bacterianas | |
| DE60142971D1 (de) | Expression biologisch aktiver polypeptide in wasserlinse | |
| DK0786009T3 (da) | Fremgangsmåde til bakteriel fremstilling af heterologe polypeptider med disulphidbindinger | |
| DK1013765T3 (da) | Fremgangsmåde til fremstilling af L-aminosyrer | |
| DK0815245T3 (da) | Bioaktive IL 12 fusionsproteiner | |
| NO963225L (no) | Multivariant IL-3 hematopoiese-fusjonsprotein | |
| RU2001110120A (ru) | Модифицированный сигнальный пептид энтеротоксина-ii e. coli и микроорганизм, экспрессирующий белок слияния упомянутого пептида с гетерологичным белком | |
| KR890014738A (ko) | 단백질 합성의 cks 방법 | |
| IL141869A0 (en) | Mammalian transforming growth factor beta-9 (ztgfss9) | |
| ZA916171B (en) | Protein structure of the plant toxin gelonin | |
| ITMI930456A1 (it) | Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis | |
| CA2327524A1 (fr) | Procede de controle de clivage par la protease de l'ompt | |
| DK0828004T3 (da) | Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær | |
| WO2002101058A1 (fr) | Nouveau promoteur | |
| SHULTZ | THE AMINO ACID SEQUENCE OF THE TYROSINE-SENSITIVE 3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE FROM ESCHERICHIA COLI K12 | |
| WO2002026978A1 (fr) | Nouvelles proteines, genes codant ces proteines et leur procede d'utilisation | |
| KR960034215A (ko) | 헬리코박터 필로리의 항원결정부위 융합단백질인 Ub-A545의 유전공학적 제조방법 | |
| CA2034385A1 (fr) | Vecteurs servant a produire des peptides importants au point de vue biologique | |
| KR950025099A (ko) | 인간 알파 아트리알 나트리 우레틱 인자의 미생물학적 제조방법 |